Total Credits: 1 including 1 AAFP Prescribed Credit(s), 1 AOA Category 1-A Credit(s)
Learning Objectives:
1. Describe different genotypes of sickle cell disease
2. Assess for sickle cell complications within several organ systems and improve osteopathic medical knowledge.
3. Summarize health maintenance and screening for children with sickle cell disease.
4. Summarize therapy options for patients with sickle cell disease.
Disclosure: This presenter has no conflict of interest or disclosure to declare of any financial interest or other relationship with any commercial entities discussed in this education presentation. This presenter does not intend to reference unlabeled/unapproved uses of drugs and/or products in this educational presentation.
Accreditation Statement
This educational presentation was developed according to the planning, design, implementation and evaluation standards of the accreditation requirements for category 1 CME sponsors of the American Osteopathic Association (AOA). The Indiana Osteopathic Association (IOA) is accredited by the AOA to provide osteopathic continuing medical education for physicians.
Grievance Policy Statement
"It is the policy of the IOA that any physician dissatisfied with the CME program will be issued a refund upon request, and no CME credits will be reported to the AOA. Complaints on Evaluation Forms also are taken into consideration when planning future CME programs and may lead to changes in the format or content." If you have any questions or concerns about this educational experience, you may call the IOA office at (317) 926-3009 or send an email message to info@inosteo.org. All questions or concerns will be addressed promptly.
| Sickle Cell Disease: More Than Just Pain (2.5 MB) | Available after Purchase | ||
Dr. Meghan Drayton Jackson is an Associate Professor of Pediatrics in the Division of Pediatric Hematology-Oncology at Indiana University School of Medicine and Riley Hospital for Children. Dr. Drayton Jackson has a special interest in caring for patients with sickle cell disease and thalassemia. She joined the Comprehensive Hemoglobinapathy Program at Riley in 2019 where she works with a multidisciplinary team to provide state-of-the-art, evidence-based, quality care using a holistic approach to meet the needs of each child and family. Dr. Drayton Jackson also has additional training in quality improvement/patient safety and applies these principles to address health care utilization and healthcare inequities. She also serves as the Pediatric Hematology/Oncology/Stem Cell Transplant Director of Quality & Safety. She received her Doctor of Osteopathic Medicine from Ohio University, completed Residency at Cleveland Clinic Children’s Hospital and Fellowship at Nationwide Children’s Hospital. Dr. Drayton Jackson also has a Master of Business in Operational Excellence from The Ohio State University.